When was StimAire founded?

StimAire was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is StimAire located?

StimAire is headquartered in Tucson, United States.

How many employees does StimAire have?

As of Jun 30, 2026, the latest employee count at StimAire is 3.

Is StimAire a funded company?

StimAire is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Nov 26, 2019.

When was the latest funding round of StimAire?

StimAire's latest funding was a $***** Seed round on Nov 26, 2019, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $3.4B in funding in 2026 to date.

Where does StimAire rank among its competitors?

StimAire ranks 28th amongst 97 active competitors, of which 25 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was BlueWind Medical, which secured $47.8M in May, 2026.

Who are the top competitors of StimAire?

StimAire's top competitors include ElectroCore, Saluda Medical and Synchron. Among them, BlueWind Medical secured the most recent funding round in May, 2026.

StimAire - 2026 Company Profile, Team, Funding & Competitors

Company Details

Stimaire is the developer of neural stimulation treatment therapy. Its neural stimulation technology is used for the treatment of pain, migraine, epilepsy, sleep apnea, and bladder control among others.

Key Metrics

Founded Year

2018

Location

Tucson, United States

Stage

Seed

Total Funding

$1.56M in 1 round

Latest Funding Round

Seed, Nov 26, 2019, $*****

Investors

UAVenture Capital Fund

Ranked

28^th among 97 active competitors

Employee Count

3 as on Jun 30, 2026

Similar Companies

ElectroCore & 104 more

View StimAire's full profile

StimAire is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Stimaire, Inc. CIN: 1794647 , United States, Active		$1 - $1M (As on Nov 26, 2019)	-	-

StimAire has raised a total funding of $1.56M over 1 round. Its latest funding round was a Seed round on Nov 26, 2019 for $*****. 1 investor participated in its latest round. StimAire has 1 institutional investor.

Here is the list of recent funding rounds of StimAire:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 26, 2019	7426577	Seed	7196796	1745021	4894369	2070064

Access funding benchmarks and valuations. Sign up today!

View details of StimAire's funding rounds and investors

The founders of StimAire are Tarek Makansi and Tarek Makansi.

Here are the details of StimAire's key team members:

Tarek Makansi: Founder of StimAire.
Tarek Makansi: Founder & CTO of StimAire.
Contact Info: 1 email address and 1 phone number

View details of StimAire's Founder profiles and Board Members

StimAire's employee count trend

StimAire has 3 employees as of Jun 26. Here is StimAire's employee count trend over the years:

Uncover StimAire's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of StimAire include ElectroCore, Saluda Medical and Synchron. Here is the list of Top 10 competitors of StimAire, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ElectroCore 2005, Basking Ridge (United States), Public	Developer of non-invasive vagus nerve stimulation devices	$161M	Core Ventures Group, Merck Global Health Innovation Fund ... & 6 others	70/100
2nd	Saluda Medical 2010, Bloomington (United States), Public	Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment	$530M	Redmile Group, BioScience Managers & 9 others	66/100
3rd	Synchron 2016, Brooklyn (United States), Series D	Developer of implantable bioelectronics for the treatment of neurological conditions	$345M	Arch Venture Partners, Khosla Ventures & 33 others	62/100
4th	ONWARD 2014, Eindhoven (Netherlands), Public	Developer of a therapeutic device for spinal cord injuries	$35M	Invest-NL, Olympic Investment & 17 others	61/100
5th	Nalu Medical 2014, Carlsbad (United States), Acquired	Developer of a neurostimulation system for managing intractable chronic pain	$231M	Gilde Healthcare, Novo Holdings & 9 others	61/100
6th	Neurovalens 2013, Belfast (United Kingdom), Series A	Developer of non-invasive neurostimulation products	$26.1M	IQ Capital, ACF Investors & 57 others	57/100
7th	BlueWind Medical 2010, Herzliya (Israel), Series B	Developer of neurostimulation device for the treatment of overactive bladder	$112M	ConvaTec, Rainbow Medical	54/100
8th	SpineX 2018, Los Angeles (United States), Seed	Developer of a medical device for neurological conditions	-	NIH, UCSF Rosenman Institute & 2 others	52/100
9th	Subsense 2022, Covina (United States), Seed	Developer of non-surgical brain-computer interfaces using biocompatible nanoparticles	$27M	Golden Falcon Capital	48/100
10th	Atlantic Therapeutics 2013, Oranmore (Ireland), Acquired	Developer of a non-invasive wearable device for pelvic floor strengthening and nerve stimulation products	$70.6M	Life Sciences Partners, Western Development Commission ... & 10 others	48/100
28th	StimAire 2018, Tucson (United States), Seed	Developer of neural stimulation treatment therapy	$1.56M	UAVenture Capital Fund	30/100